Loading…

Strong Inhibition of 2‐Amino‐6‐methyldipyrido[l,2‐a:3′,2′‐d]imidazole‐induced Mutagenesis and Hepatocarcinogenesis by 1‐O‐Hexyl‐2,3,5‐trimethylhydroquinone

The effects of 3‐O‐dodecylcarbomethylascorbic acid (3‐O‐DAsA), 3‐O‐ethylascorbic acid (3‐O‐EAsA) and 1‐O‐hexy1‐2,3,5‐trimethylhydroquinone (HTHQ) on 2‐amino‐6‐methyldipyrido[l,2‐a:3′,2′‐d]‐imidazole (Glu‐P‐1)‐induced mutagenesis and hepatocarcinogenesis were examined. In a Salmonella assay, addition...

Full description

Saved in:
Bibliographic Details
Published in:Cancer science 1993-05, Vol.84 (5), p.481-484
Main Authors: Hirose, Masao, Akagi, Keisuke, Hasegawa, Ryohei, Satoh, Toshio, Nihro, Yasunori, Miki, Tokutaro, Sugimura, Takashi, Ito, Nobuyuki
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5331-3f3a72a7af00fd8be9e181edf12349023d64ca3b573a40bf24eed506da4f8d783
cites cdi_FETCH-LOGICAL-c5331-3f3a72a7af00fd8be9e181edf12349023d64ca3b573a40bf24eed506da4f8d783
container_end_page 484
container_issue 5
container_start_page 481
container_title Cancer science
container_volume 84
creator Hirose, Masao
Akagi, Keisuke
Hasegawa, Ryohei
Satoh, Toshio
Nihro, Yasunori
Miki, Tokutaro
Sugimura, Takashi
Ito, Nobuyuki
description The effects of 3‐O‐dodecylcarbomethylascorbic acid (3‐O‐DAsA), 3‐O‐ethylascorbic acid (3‐O‐EAsA) and 1‐O‐hexy1‐2,3,5‐trimethylhydroquinone (HTHQ) on 2‐amino‐6‐methyldipyrido[l,2‐a:3′,2′‐d]‐imidazole (Glu‐P‐1)‐induced mutagenesis and hepatocarcinogenesis were examined. In a Salmonella assay, addition of 2.5 to 20.0 rag of HTHQ to Salmonella TA 98 in the presence of S‐9 mixture dose‐dependently inhibited Glu‐P‐1‐induced mutagenesis. The highest dose showed a 99% reduction in revertants. 3‐O‐DAsA and 3‐O‐EAsA were without effect. In an animal study using the medium‐term bioassay system for the detection of hepatocarcinogens or hepatopromoters in F344 male rats, treatment with Glu‐P‐1 alone was associated with a significant increase in the number and area of GST‐P‐positive foci (47.5±8.9 and 11.1±4.7, respectively). Combined treatment with 1.0% HTHQ significantly reduced the number and area of GST‐P‐positive foci (to 8.1±2.1 and 0.6±0.2) while 3‐O‐DASA exerted marginal inhibition and 3‐O‐EAsA had no effect. On the other hand, all three of these compounds slightly enhanced the numbers and areas of foci when given alone. The results indicate that HTHQ is a potent chemopreventer of Glu‐P‐1‐induced hepatocarcinogenesis.
doi_str_mv 10.1111/j.1349-7006.1993.tb00162.x
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5919179</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2399199500</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5331-3f3a72a7af00fd8be9e181edf12349023d64ca3b573a40bf24eed506da4f8d783</originalsourceid><addsrcrecordid>eNqVUctuEzEUtRCopIVPQBoBy8zgxzy7QIqiQioVdQGsELI8YztxNLFTewKZrvoJfEv5o34Jd5QhwBJLV9fWOef62AehlwQnBNabdUJYWsUFxnlCqoolXY0xyWmyf4QmR-gxmuCK4DjDGX6KTkNYA6nAOT1BJyWjIGAT9PNj551dRpd2ZWrTGWcjpyP6cPdjtjHWQc-hNqpb9a00294b6b6004EgztnD3f2wvYeT_Go2Ropb1yo4GSt3jZLRh10nlsqqYEIkrIwWais61wjfwPDfQN1HBDTXUAu171vodMqmGfTOm8Pdq156d7MDlVXP0BMt2qCej_0MfX538Wm-iK-u31_OZ1dxkzFGYqaZKKgohMZYy7JWlSIlUVITCl-EKZN52ghWZwUTKa41TZWSGc6lSHUpi5KdobeHudtdvVGyUbbzouVb8CR8z50w_F_EmhVfum88q0hFigoGvBoHDN5V6Pja7bwFz5yyCkhVhjGwzg-sxrsQvNLHGwjmQ958zYdQ-RAqH_LmY958D-IXf3s8SseAAX894iI0otVe2MaEIy0t8rIs6J-nfjet6v_DAJ_PLtKSsF-tBNdt</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2399199500</pqid></control><display><type>article</type><title>Strong Inhibition of 2‐Amino‐6‐methyldipyrido[l,2‐a:3′,2′‐d]imidazole‐induced Mutagenesis and Hepatocarcinogenesis by 1‐O‐Hexyl‐2,3,5‐trimethylhydroquinone</title><source>PubMed Central Free</source><source>ProQuest - Publicly Available Content Database</source><creator>Hirose, Masao ; Akagi, Keisuke ; Hasegawa, Ryohei ; Satoh, Toshio ; Nihro, Yasunori ; Miki, Tokutaro ; Sugimura, Takashi ; Ito, Nobuyuki</creator><creatorcontrib>Hirose, Masao ; Akagi, Keisuke ; Hasegawa, Ryohei ; Satoh, Toshio ; Nihro, Yasunori ; Miki, Tokutaro ; Sugimura, Takashi ; Ito, Nobuyuki</creatorcontrib><description>The effects of 3‐O‐dodecylcarbomethylascorbic acid (3‐O‐DAsA), 3‐O‐ethylascorbic acid (3‐O‐EAsA) and 1‐O‐hexy1‐2,3,5‐trimethylhydroquinone (HTHQ) on 2‐amino‐6‐methyldipyrido[l,2‐a:3′,2′‐d]‐imidazole (Glu‐P‐1)‐induced mutagenesis and hepatocarcinogenesis were examined. In a Salmonella assay, addition of 2.5 to 20.0 rag of HTHQ to Salmonella TA 98 in the presence of S‐9 mixture dose‐dependently inhibited Glu‐P‐1‐induced mutagenesis. The highest dose showed a 99% reduction in revertants. 3‐O‐DAsA and 3‐O‐EAsA were without effect. In an animal study using the medium‐term bioassay system for the detection of hepatocarcinogens or hepatopromoters in F344 male rats, treatment with Glu‐P‐1 alone was associated with a significant increase in the number and area of GST‐P‐positive foci (47.5±8.9 and 11.1±4.7, respectively). Combined treatment with 1.0% HTHQ significantly reduced the number and area of GST‐P‐positive foci (to 8.1±2.1 and 0.6±0.2) while 3‐O‐DASA exerted marginal inhibition and 3‐O‐EAsA had no effect. On the other hand, all three of these compounds slightly enhanced the numbers and areas of foci when given alone. The results indicate that HTHQ is a potent chemopreventer of Glu‐P‐1‐induced hepatocarcinogenesis.</description><identifier>ISSN: 0910-5050</identifier><identifier>ISSN: 1347-9032</identifier><identifier>EISSN: 1349-7006</identifier><identifier>EISSN: 1876-4673</identifier><identifier>DOI: 10.1111/j.1349-7006.1993.tb00162.x</identifier><identifier>PMID: 8320163</identifier><identifier>CODEN: GANNA2</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Animals ; Anticarcinogenic Agents - pharmacology ; Antimutagenic Agents - pharmacology ; Antioxidant ; Antioxidants - pharmacology ; Anti‐mutagenesis ; Ascorbic Acid - pharmacology ; Biological and medical sciences ; Body Weight - drug effects ; Carcinogenesis, carcinogens and anticarcinogens ; Chemical agents ; Chemoprevention ; Hepatocarcinogenesis ; Heterocyclic amine ; Hydroquinones - pharmacology ; Imidazole ; Imidazoles - toxicity ; Liver Neoplasms, Experimental - chemically induced ; Liver Neoplasms, Experimental - prevention &amp; control ; Male ; Medical sciences ; Mutagenesis ; Mutagens - toxicity ; Rapid Communication ; Rats ; Rats, Inbred F344 ; Revertants ; Salmonella ; Tumors</subject><ispartof>Cancer science, 1993-05, Vol.84 (5), p.481-484</ispartof><rights>1993 INIST-CNRS</rights><rights>Copyright John Wiley &amp; Sons, Inc. May 1993</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5331-3f3a72a7af00fd8be9e181edf12349023d64ca3b573a40bf24eed506da4f8d783</citedby><cites>FETCH-LOGICAL-c5331-3f3a72a7af00fd8be9e181edf12349023d64ca3b573a40bf24eed506da4f8d783</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2399199500/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2399199500?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4768872$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8320163$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hirose, Masao</creatorcontrib><creatorcontrib>Akagi, Keisuke</creatorcontrib><creatorcontrib>Hasegawa, Ryohei</creatorcontrib><creatorcontrib>Satoh, Toshio</creatorcontrib><creatorcontrib>Nihro, Yasunori</creatorcontrib><creatorcontrib>Miki, Tokutaro</creatorcontrib><creatorcontrib>Sugimura, Takashi</creatorcontrib><creatorcontrib>Ito, Nobuyuki</creatorcontrib><title>Strong Inhibition of 2‐Amino‐6‐methyldipyrido[l,2‐a:3′,2′‐d]imidazole‐induced Mutagenesis and Hepatocarcinogenesis by 1‐O‐Hexyl‐2,3,5‐trimethylhydroquinone</title><title>Cancer science</title><addtitle>Jpn J Cancer Res</addtitle><description>The effects of 3‐O‐dodecylcarbomethylascorbic acid (3‐O‐DAsA), 3‐O‐ethylascorbic acid (3‐O‐EAsA) and 1‐O‐hexy1‐2,3,5‐trimethylhydroquinone (HTHQ) on 2‐amino‐6‐methyldipyrido[l,2‐a:3′,2′‐d]‐imidazole (Glu‐P‐1)‐induced mutagenesis and hepatocarcinogenesis were examined. In a Salmonella assay, addition of 2.5 to 20.0 rag of HTHQ to Salmonella TA 98 in the presence of S‐9 mixture dose‐dependently inhibited Glu‐P‐1‐induced mutagenesis. The highest dose showed a 99% reduction in revertants. 3‐O‐DAsA and 3‐O‐EAsA were without effect. In an animal study using the medium‐term bioassay system for the detection of hepatocarcinogens or hepatopromoters in F344 male rats, treatment with Glu‐P‐1 alone was associated with a significant increase in the number and area of GST‐P‐positive foci (47.5±8.9 and 11.1±4.7, respectively). Combined treatment with 1.0% HTHQ significantly reduced the number and area of GST‐P‐positive foci (to 8.1±2.1 and 0.6±0.2) while 3‐O‐DASA exerted marginal inhibition and 3‐O‐EAsA had no effect. On the other hand, all three of these compounds slightly enhanced the numbers and areas of foci when given alone. The results indicate that HTHQ is a potent chemopreventer of Glu‐P‐1‐induced hepatocarcinogenesis.</description><subject>Animals</subject><subject>Anticarcinogenic Agents - pharmacology</subject><subject>Antimutagenic Agents - pharmacology</subject><subject>Antioxidant</subject><subject>Antioxidants - pharmacology</subject><subject>Anti‐mutagenesis</subject><subject>Ascorbic Acid - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Body Weight - drug effects</subject><subject>Carcinogenesis, carcinogens and anticarcinogens</subject><subject>Chemical agents</subject><subject>Chemoprevention</subject><subject>Hepatocarcinogenesis</subject><subject>Heterocyclic amine</subject><subject>Hydroquinones - pharmacology</subject><subject>Imidazole</subject><subject>Imidazoles - toxicity</subject><subject>Liver Neoplasms, Experimental - chemically induced</subject><subject>Liver Neoplasms, Experimental - prevention &amp; control</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mutagenesis</subject><subject>Mutagens - toxicity</subject><subject>Rapid Communication</subject><subject>Rats</subject><subject>Rats, Inbred F344</subject><subject>Revertants</subject><subject>Salmonella</subject><subject>Tumors</subject><issn>0910-5050</issn><issn>1347-9032</issn><issn>1349-7006</issn><issn>1876-4673</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNqVUctuEzEUtRCopIVPQBoBy8zgxzy7QIqiQioVdQGsELI8YztxNLFTewKZrvoJfEv5o34Jd5QhwBJLV9fWOef62AehlwQnBNabdUJYWsUFxnlCqoolXY0xyWmyf4QmR-gxmuCK4DjDGX6KTkNYA6nAOT1BJyWjIGAT9PNj551dRpd2ZWrTGWcjpyP6cPdjtjHWQc-hNqpb9a00294b6b6004EgztnD3f2wvYeT_Go2Ropb1yo4GSt3jZLRh10nlsqqYEIkrIwWais61wjfwPDfQN1HBDTXUAu171vodMqmGfTOm8Pdq156d7MDlVXP0BMt2qCej_0MfX538Wm-iK-u31_OZ1dxkzFGYqaZKKgohMZYy7JWlSIlUVITCl-EKZN52ghWZwUTKa41TZWSGc6lSHUpi5KdobeHudtdvVGyUbbzouVb8CR8z50w_F_EmhVfum88q0hFigoGvBoHDN5V6Pja7bwFz5yyCkhVhjGwzg-sxrsQvNLHGwjmQ958zYdQ-RAqH_LmY958D-IXf3s8SseAAX894iI0otVe2MaEIy0t8rIs6J-nfjet6v_DAJ_PLtKSsF-tBNdt</recordid><startdate>199305</startdate><enddate>199305</enddate><creator>Hirose, Masao</creator><creator>Akagi, Keisuke</creator><creator>Hasegawa, Ryohei</creator><creator>Satoh, Toshio</creator><creator>Nihro, Yasunori</creator><creator>Miki, Tokutaro</creator><creator>Sugimura, Takashi</creator><creator>Ito, Nobuyuki</creator><general>Blackwell Publishing Ltd</general><general>Japanese Cancer Association</general><general>John Wiley &amp; Sons, Inc</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FE</scope><scope>8FH</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>199305</creationdate><title>Strong Inhibition of 2‐Amino‐6‐methyldipyrido[l,2‐a:3′,2′‐d]imidazole‐induced Mutagenesis and Hepatocarcinogenesis by 1‐O‐Hexyl‐2,3,5‐trimethylhydroquinone</title><author>Hirose, Masao ; Akagi, Keisuke ; Hasegawa, Ryohei ; Satoh, Toshio ; Nihro, Yasunori ; Miki, Tokutaro ; Sugimura, Takashi ; Ito, Nobuyuki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5331-3f3a72a7af00fd8be9e181edf12349023d64ca3b573a40bf24eed506da4f8d783</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Animals</topic><topic>Anticarcinogenic Agents - pharmacology</topic><topic>Antimutagenic Agents - pharmacology</topic><topic>Antioxidant</topic><topic>Antioxidants - pharmacology</topic><topic>Anti‐mutagenesis</topic><topic>Ascorbic Acid - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Body Weight - drug effects</topic><topic>Carcinogenesis, carcinogens and anticarcinogens</topic><topic>Chemical agents</topic><topic>Chemoprevention</topic><topic>Hepatocarcinogenesis</topic><topic>Heterocyclic amine</topic><topic>Hydroquinones - pharmacology</topic><topic>Imidazole</topic><topic>Imidazoles - toxicity</topic><topic>Liver Neoplasms, Experimental - chemically induced</topic><topic>Liver Neoplasms, Experimental - prevention &amp; control</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mutagenesis</topic><topic>Mutagens - toxicity</topic><topic>Rapid Communication</topic><topic>Rats</topic><topic>Rats, Inbred F344</topic><topic>Revertants</topic><topic>Salmonella</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hirose, Masao</creatorcontrib><creatorcontrib>Akagi, Keisuke</creatorcontrib><creatorcontrib>Hasegawa, Ryohei</creatorcontrib><creatorcontrib>Satoh, Toshio</creatorcontrib><creatorcontrib>Nihro, Yasunori</creatorcontrib><creatorcontrib>Miki, Tokutaro</creatorcontrib><creatorcontrib>Sugimura, Takashi</creatorcontrib><creatorcontrib>Ito, Nobuyuki</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Biological Science Database</collection><collection>ProQuest - Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hirose, Masao</au><au>Akagi, Keisuke</au><au>Hasegawa, Ryohei</au><au>Satoh, Toshio</au><au>Nihro, Yasunori</au><au>Miki, Tokutaro</au><au>Sugimura, Takashi</au><au>Ito, Nobuyuki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Strong Inhibition of 2‐Amino‐6‐methyldipyrido[l,2‐a:3′,2′‐d]imidazole‐induced Mutagenesis and Hepatocarcinogenesis by 1‐O‐Hexyl‐2,3,5‐trimethylhydroquinone</atitle><jtitle>Cancer science</jtitle><addtitle>Jpn J Cancer Res</addtitle><date>1993-05</date><risdate>1993</risdate><volume>84</volume><issue>5</issue><spage>481</spage><epage>484</epage><pages>481-484</pages><issn>0910-5050</issn><issn>1347-9032</issn><eissn>1349-7006</eissn><eissn>1876-4673</eissn><coden>GANNA2</coden><abstract>The effects of 3‐O‐dodecylcarbomethylascorbic acid (3‐O‐DAsA), 3‐O‐ethylascorbic acid (3‐O‐EAsA) and 1‐O‐hexy1‐2,3,5‐trimethylhydroquinone (HTHQ) on 2‐amino‐6‐methyldipyrido[l,2‐a:3′,2′‐d]‐imidazole (Glu‐P‐1)‐induced mutagenesis and hepatocarcinogenesis were examined. In a Salmonella assay, addition of 2.5 to 20.0 rag of HTHQ to Salmonella TA 98 in the presence of S‐9 mixture dose‐dependently inhibited Glu‐P‐1‐induced mutagenesis. The highest dose showed a 99% reduction in revertants. 3‐O‐DAsA and 3‐O‐EAsA were without effect. In an animal study using the medium‐term bioassay system for the detection of hepatocarcinogens or hepatopromoters in F344 male rats, treatment with Glu‐P‐1 alone was associated with a significant increase in the number and area of GST‐P‐positive foci (47.5±8.9 and 11.1±4.7, respectively). Combined treatment with 1.0% HTHQ significantly reduced the number and area of GST‐P‐positive foci (to 8.1±2.1 and 0.6±0.2) while 3‐O‐DASA exerted marginal inhibition and 3‐O‐EAsA had no effect. On the other hand, all three of these compounds slightly enhanced the numbers and areas of foci when given alone. The results indicate that HTHQ is a potent chemopreventer of Glu‐P‐1‐induced hepatocarcinogenesis.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>8320163</pmid><doi>10.1111/j.1349-7006.1993.tb00162.x</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0910-5050
ispartof Cancer science, 1993-05, Vol.84 (5), p.481-484
issn 0910-5050
1347-9032
1349-7006
1876-4673
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5919179
source PubMed Central Free; ProQuest - Publicly Available Content Database
subjects Animals
Anticarcinogenic Agents - pharmacology
Antimutagenic Agents - pharmacology
Antioxidant
Antioxidants - pharmacology
Anti‐mutagenesis
Ascorbic Acid - pharmacology
Biological and medical sciences
Body Weight - drug effects
Carcinogenesis, carcinogens and anticarcinogens
Chemical agents
Chemoprevention
Hepatocarcinogenesis
Heterocyclic amine
Hydroquinones - pharmacology
Imidazole
Imidazoles - toxicity
Liver Neoplasms, Experimental - chemically induced
Liver Neoplasms, Experimental - prevention & control
Male
Medical sciences
Mutagenesis
Mutagens - toxicity
Rapid Communication
Rats
Rats, Inbred F344
Revertants
Salmonella
Tumors
title Strong Inhibition of 2‐Amino‐6‐methyldipyrido[l,2‐a:3′,2′‐d]imidazole‐induced Mutagenesis and Hepatocarcinogenesis by 1‐O‐Hexyl‐2,3,5‐trimethylhydroquinone
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T13%3A05%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Strong%20Inhibition%20of%202%E2%80%90Amino%E2%80%906%E2%80%90methyldipyrido%5Bl,2%E2%80%90a:3%E2%80%B2,2%E2%80%B2%E2%80%90d%5Dimidazole%E2%80%90induced%20Mutagenesis%20and%20Hepatocarcinogenesis%20by%201%E2%80%90O%E2%80%90Hexyl%E2%80%902,3,5%E2%80%90trimethylhydroquinone&rft.jtitle=Cancer%20science&rft.au=Hirose,%20Masao&rft.date=1993-05&rft.volume=84&rft.issue=5&rft.spage=481&rft.epage=484&rft.pages=481-484&rft.issn=0910-5050&rft.eissn=1349-7006&rft.coden=GANNA2&rft_id=info:doi/10.1111/j.1349-7006.1993.tb00162.x&rft_dat=%3Cproquest_pubme%3E2399199500%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5331-3f3a72a7af00fd8be9e181edf12349023d64ca3b573a40bf24eed506da4f8d783%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2399199500&rft_id=info:pmid/8320163&rfr_iscdi=true